Last reviewed · How we verify
NCT05437939: Mulisa
Adverse Outcomes Following Female Genital Fistula Repair
trial in Female Genital Fistula in 802 participants. Participants enrolled and being followed up; not accepting new ones.
31 March 2026
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 802 |
| Start date | 20 May 2022 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Uganda |
Conditions studied
- Female Genital Fistula — all drugs for Female Genital Fistula →
- Incontinence — all drugs for Incontinence →
Sponsor
University of California, San Francisco
Who can join
15 and older, female only, with Female Genital Fistula or Incontinence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Following genital fistula repair, fistula repair breakdown and recurrence, persistent and incidence incontinence are major adverse outcomes, limiting women's health and wellbeing. Using a prospective design, the investigators seek to identify modifiable risk factors to establish key targets for intervention, followed by qualitative work to refine the feasibility and acceptability of potential intervention strategies.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Identifying opportunities for prevention of adverse outcomes following female genital fistula repair: protocol for a mixed-methods study in Uganda.
El Ayadi AM, Obore S, Kirya F, Miller S, et al · · 2024 · PMID 38178156 · DOI 10.1186/s12978-023-01732-7 -
Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital Fistula Repair: Protocol for a Mixed-Methods Study in Uganda
Ayadi AME, Obore S, Kirya F, Miller S, et al · · 2023 · DOI 10.21203/rs.3.rs-2879899/v1
Verify or expand the search:
- PubMed search for NCT05437939
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05437939 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 7 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05437939.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing